CV Sciences, Inc.
CVSI
$0.0309
-$0.0051-14.17%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.25% | -1.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.25% | -1.20% | |||
| Cost of Revenue | -0.33% | -2.56% | |||
| Gross Profit | -4.41% | 0.38% | |||
| SG&A Expenses | 4.96% | -21.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.20% | -12.66% | |||
| Operating Income | -214.46% | 86.61% | |||
| Income Before Tax | 21.92% | 6.11% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 21.92% | 7.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.92% | 7.01% | |||
| EBIT | -214.46% | 86.61% | |||
| EBITDA | -2,471.43% | 98.74% | |||
| EPS Basic | 26.47% | 12.82% | |||
| Normalized Basic EPS | -333.33% | 87.50% | |||
| EPS Diluted | 26.47% | 12.82% | |||
| Normalized Diluted EPS | -333.33% | 87.50% | |||
| Average Basic Shares Outstanding | 5.71% | 5.73% | |||
| Average Diluted Shares Outstanding | 5.71% | 5.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
